Various radiopharmacueticals
Ended Awarded Last action
- Contract number
- W81K0024F0109
- Awardee
-
Petnet Solutions, Inc. UEI Z63RLN31BEE5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $300,000 | |
| Original award | $0 |
About this award
Petnet Solutions, Inc., a Knoxville, Tennessee-based manufacturer of specialized radiopharmaceutical products and subsidiary of Siemens Aktiengesellschaft, was awarded a $300,000 blanket purchase agreement call by the Defense Health Agency on October 1, 2024, for the supply of various radiopharmaceuticals to support diagnostic imaging services at military treatment facilities. The contract, structured as a firm fixed-price delivery order with performance at Fort Sam Houston, Texas, will conclude on September 30, 2025. This award reflects Petnet Solutions' established role as a key supplier of advanced medical imaging agents, including fluorodeoxyglucose (FDG) and specialized PET and CT scan agents, which are essential diagnostic tools for detecting cancer, neurological disorders, and cardiac diseases across federal healthcare networks.
This BPA call represents one component of Petnet Solutions' substantial federal procurement portfolio, which includes multiple indefinite delivery contracts and blanket purchase agreements with the Department of Veterans Affairs across numerous Veterans Integrated Service Networks and the Defense Health Agency. The award carries no set-aside designation, reflecting the contractor's competitive standing and the specialized, proprietary nature of radiopharmaceutical manufacturing. By leveraging established procurement vehicles, this contract enables the Defense Health Agency to efficiently procure critical radiopharmaceutical products on an as-needed basis to support nuclear medicine and diagnostic imaging operations at military medical facilities serving active-duty military personnel and beneficiaries.
Quick answers
Who was awarded contract W81K0024F0109?
W81K0024F0109 was awarded to Petnet Solutions, Inc. by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0024F0109 worth?
The government has obligated $300,000 on W81K0024F0109.
Which agency awarded contract W81K0024F0109?
Medical Command (Department of the Army) awarded W81K0024F0109, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0024F0109 an order under another contract?
Yes. W81K0024F0109 is a BPA call under W81K0020A0011, a blanket purchase agreement.
Was contract W81K0024F0109 competed?
The extent of competition for W81K0024F0109 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award